Comparison of High Flow Nasal Cannula and Non-Invasive Ventilation After Planned Extubation in Children Following Heart Surgery

What this Trial Is About

Researchers are comparing two breathing support methods, High Flow Nasal Cannula HFNC and Non-Invasive Ventilation NIV, in children under 18 who have undergone heart surgery and are in the cardiac intensive care unit. The study focuses on how well these methods help prevent the need for reintubation within 48 to 72 hours after planned extubation. It also aims to identify factors that contribute to extubation failure in high-risk pediatric patients. Participants will be randomly assigned to receive either HFNC therapy using the Airvo3 Nasal High Flow System or NIV with standard ICU ventilator settings tailored to each childs condition immediately after extubation. The study will monitor each groups length of stay in the cardiac intensive care unit, sedation use, and comfort levels measured by the COMFORT scale. Children in the trial will be closely observed for the need for reintubation, duration and amount of sedation, and changes in comfort scores up to 72 hours after extubation. Researchers will also track how long each child stays in intensive care. The total participation time varies but includes monitoring during the critical first few days after surgery. This allows a thorough evaluation of both breathing support methods and their impact on recovery.

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery